trending Market Intelligence /marketintelligence/en/news-insights/trending/uhoAd34OCvT77yQJfhTi0w2 content esgSubNav
In This List

Indian high court grants Reckitt Benckiser rights to advertise Ayurvedic drugs

Blog

Christopher & Banks Corporation – tracking the early-warning signals of credit risk

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch


Indian high court grants Reckitt Benckiser rights to advertise Ayurvedic drugs

The Delhi High Court has ordered an Indian government body not to take coercive actions against consumer goods giant Reckitt Benckiser Group PLC if it advertises its Ayurvedic, Siddha and Unani range of medicines, The Economic Times (India) reported Jan. 15, citing a court filing.

The ruling follows an appeal by the Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy, to prohibit the U.K.-based company from selling its range of drugs under the country's drugs and cosmetics laws, according to the report.

Reckitt Benckiser argued in court that the company has a manufacturing license to sell its range of products, which include Strepsils, Moov, Krack cream and Dermicool talcum powder, the report said.